SOUTH KOREA · OPENDART
Gencurix Inc.
젠큐릭스 · 229000 · KOSDAQ · Healthcare · Diagnostics & Research
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-23 | Moon Young Ho | Vice president | Sold on the exchange | 5,753 | ₩3,470 | ₩20.0M | DART ↗ |
Other changes in holdings · 5
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-09-11 | AHN SEI HYUN | Outside director | Merger(+) | 10,670 | DART ↗ |
| 2026-09-11 | Jung Jin-gu | Non-executive director | Merger(+) | 86,764 | DART ↗ |
| 2026-06-01 | HWANG KUM MIN | Managing director | New appointment(+) | 9,000 | DART ↗ |
| 2026-01-01 | CHO SANG RAE | CEO | Acquisition of paid-in new shares(+) | 5,994,550 | DART ↗ |
| 2025-12-31 | CHO SANG RAE | CEO | CB acquisition(+) | 65,789 | DART ↗ |